Prespecified subgroup analysesĭomenico Luca Grieco, MD Luca S. Menga, MD Melania Cesarano, MD Tommaso Rosà, MD Savino Spadaro, MD, PhD Maria Maddalena Bitondo, MD Jonathan Montomoli, MD, PhD Giulia Falò, MD Tommaso Tonetti, MD Salvatore L. Cutuli, MD Gabriele Pintaudi, MD Eloisa S. Tanzarella, MD Edoardo Piervincenzi, MD Filippo Bongiovanni, MD Antonio M. Dell’Anna, MD Luca Delle Cese, MD Cecilia Berardi, MD Simone Carelli, MD Maria Grazia Bocci, MD Luca Montini, MD Giuseppe Bello, MD Daniele Natalini, MD Gennaro De Pascale, MD Matteo Velardo, PhD Carlo Alberto Volta, MD V. Serial respiratory rate, SaO2:FiO2, dyspnea visual analog scale, device discomfort visual analog scale, SOFA scores, and partial pressure of carbon dioxide (PaCO2)ĮFigure 5. Kaplan-Meier time-to-event curves for 28-day mortality (Panel A) and intubation (Panel B) in the per-protocol populationĮFigure 4. Dyspnea visual analog scale and device discomfort visual analog scalesĮFigure 3. Bedside poster for the initial settings of helmet noninvasive ventilation and general guidelines for intubationĮFigure 2. Additional information on secondary and adverse eventsĮTable 11. Additional analyses on primary outcomeĮTable 10. Additional information on interventions and co-interventionsĮTable 9. Additional baseline characteristicsĮTable 8. Patient enrollment by participating sitesĮTable 7. Prespecified and post hoc subgroupsĮTable 6. Primary outcome, secondary outcomes, and adverse eventsĮTable 5. Inclusion and exclusion criteriaĮTable 4. Helmet noninvasive ventilation protocolĮTable 3. Characteristics of participating sitesĮTable 2.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |